![](/img/cover-not-exists.png)
441O Preliminary safety and clinical activity of erlotinib plus atezolizumab from a Phase Ib study in advanced NSCLC
Ma, B.B.Y., Rudin, C.M., Cervantes, A., Dowlati, A., Costa, D., Schmid, P., Heist, R., Villaflor, V.M., Sarkar, I., Huseni, M.A., Foster, P., O'Hear, C., Gettinger, S., Besse, B.Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw594.005
Date:
December, 2016
File:
PDF, 49 KB
english, 2016